BR9608390A - Método para minimizar a perda óssea - Google Patents

Método para minimizar a perda óssea

Info

Publication number
BR9608390A
BR9608390A BR9608390A BR9608390A BR9608390A BR 9608390 A BR9608390 A BR 9608390A BR 9608390 A BR9608390 A BR 9608390A BR 9608390 A BR9608390 A BR 9608390A BR 9608390 A BR9608390 A BR 9608390A
Authority
BR
Brazil
Prior art keywords
bone loss
minimize bone
minimize
loss
bone
Prior art date
Application number
BR9608390A
Other languages
English (en)
Inventor
George Joseph Cullinan
Steven Anthony Fontana
Robin Sharon Lee Fuchs-Youg
Andrew Lawrence Glasebrook
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9608390A publication Critical patent/BR9608390A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR9608390A 1995-06-06 1996-06-05 Método para minimizar a perda óssea BR9608390A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47111195A 1995-06-06 1995-06-06
PCT/US1996/008810 WO1996039141A1 (en) 1995-06-06 1996-06-05 Methods for minimizing bone loss

Publications (1)

Publication Number Publication Date
BR9608390A true BR9608390A (pt) 1999-05-04

Family

ID=23870302

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608390A BR9608390A (pt) 1995-06-06 1996-06-05 Método para minimizar a perda óssea

Country Status (27)

Country Link
EP (1) EP0747056B1 (pt)
JP (1) JP2001501907A (pt)
KR (1) KR19990022497A (pt)
CN (1) CN1239429A (pt)
AR (2) AR003002A1 (pt)
AT (1) ATE187643T1 (pt)
AU (1) AU696927B2 (pt)
BR (1) BR9608390A (pt)
CA (1) CA2223174A1 (pt)
CO (1) CO4700447A1 (pt)
CZ (1) CZ383097A3 (pt)
DE (1) DE69605600T2 (pt)
DK (1) DK0747056T3 (pt)
EA (1) EA199800014A1 (pt)
ES (1) ES2142545T3 (pt)
GR (1) GR3032863T3 (pt)
HU (1) HUP9900854A3 (pt)
IL (1) IL118573A (pt)
NO (1) NO975560L (pt)
PE (1) PE2298A1 (pt)
PL (1) PL323941A1 (pt)
PT (1) PT747056E (pt)
SI (1) SI0747056T1 (pt)
TR (1) TR199701508T1 (pt)
WO (1) WO1996039141A1 (pt)
YU (1) YU34296A (pt)
ZA (1) ZA964681B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023740A1 (en) * 1996-11-22 1998-06-04 Akzo Nobel N.V. Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
US5393785A (en) * 1988-10-31 1995-02-28 Endorecherche, Inc. Therapeutic antiestrogens
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
DE4329344A1 (de) * 1993-08-27 1995-03-02 Schering Ag Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri

Also Published As

Publication number Publication date
PE2298A1 (es) 1998-02-28
ATE187643T1 (de) 2000-01-15
DE69605600D1 (de) 2000-01-20
ZA964681B (en) 1997-12-05
CO4700447A1 (es) 1998-12-29
AR003002A1 (es) 1998-05-27
YU34296A (en) 1999-11-22
TR199701508T1 (xx) 1998-03-21
IL118573A0 (en) 1996-10-16
IL118573A (en) 2000-01-31
NO975560L (no) 1998-01-26
KR19990022497A (ko) 1999-03-25
ES2142545T3 (es) 2000-04-16
NO975560D0 (no) 1997-12-02
CZ383097A3 (cs) 1998-09-16
AU5981696A (en) 1996-12-24
AU696927B2 (en) 1998-09-24
CN1239429A (zh) 1999-12-22
DE69605600T2 (de) 2000-05-31
CA2223174A1 (en) 1996-12-12
HUP9900854A2 (hu) 1999-08-30
EA199800014A1 (ru) 1998-06-25
EP0747056B1 (en) 1999-12-15
HUP9900854A3 (en) 2000-03-28
JP2001501907A (ja) 2001-02-13
EP0747056A3 (en) 1997-03-05
PL323941A1 (en) 1998-04-27
EP0747056A2 (en) 1996-12-11
SI0747056T1 (en) 2000-06-30
GR3032863T3 (en) 2000-07-31
AR003134A1 (es) 1998-07-08
WO1996039141A1 (en) 1996-12-12
PT747056E (pt) 2000-05-31
DK0747056T3 (da) 2000-05-01

Similar Documents

Publication Publication Date Title
BR9610999A (pt) Processo para perfurar seletivamente uma textura não-tecida
DE69635311D1 (de) Elektrochirugische gewebeentfernung
BR9508190A (pt) Método para fabricar prepreg
BR9610578A (pt) Método para a fabricação de cerdas em rosca
BR9606782A (pt) Processo para preparar ciclopilacetileno
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
DE59600877D1 (de) Schneidvorrichtung
BR9611829A (pt) Escova de dentes e método para fabricar uma escova de dentes
BR9608389A (pt) Método para minimizar a perda óssea
FI98770C (fi) Hierarkkinen synkronointimenetelmä
BR9605410A (pt) Processo para preparar nicotinamida
FI95978C (fi) Hierarkkinen synkronointimenetelmä
BR9612080A (pt) Método para fazer uma estrutura de defesa protetiva
BR9608084A (pt) Palheta para um transportador
FI940980A0 (fi) Hierarkkinen synkronointimenetelmä
BR9508371A (pt) Processo para preparação de uma cloridrina
FI940926A0 (fi) Hierarkkinen synkronointimenetelmä
BR9408521A (pt) Método para sintetizar gama-pironas
BR9608390A (pt) Método para minimizar a perda óssea
BR9708740A (pt) Método para a fabricação de escovas
FI972592A (fi) Synkronointimenetelmä
KR970006291A (ko) 치환된 아미노카보닐트리아졸리논의 제조방법
BR9611833A (pt) Processo para a preparação de dioxoazabiciclo-hexanos
BR9601156A (pt) Processo para a preparação de aciloxialconossulfonatos
BR9602397A (pt) Processo para preparar 8-hidróxi-quinolinas substituídas

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]